Research Programme: Lead 212 conjugated targeted therapies - Mannheim Molecular Intervention Environment/Orano Med
Alternative Names: 212Pb TAT - Mannheim Molecular Intervention Environment/Orano MedLatest Information Update: 18 Sep 2023
At a glance
- Originator Mannheim Molecular Intervention Environment; Orano Med
- Class Antineoplastics; Drug conjugates; Imaging agents; Lead radioisotopes; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters; Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 22 Aug 2023 Early research in Cancer (Diagnosis) in USA (unspecified route)
- 22 Aug 2023 Early research in Cancer in USA (unspecified route)